Tenet Healthcare (THC) Updates FY18 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY18 earnings guidance on Tuesday morning. The company provided EPS guidance of $1.07-1.36 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.38. The company issued revenue guidance of $17.8-18.2 billion, compared to the consensus revenue estimate of $18.61 billion.

Tenet Healthcare (NYSE:THC) traded up $0.82 during midday trading on Friday, hitting $16.25. The company had a trading volume of 5,472,117 shares, compared to its average volume of 2,302,733. The company has a quick ratio of 1.21, a current ratio of 1.28 and a debt-to-equity ratio of 21.21. The company has a market capitalization of $1,640.00, a PE ratio of -2.95, a PEG ratio of 2.13 and a beta of 1.17. Tenet Healthcare has a 12 month low of $12.25 and a 12 month high of $22.72.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Monday, November 6th. The company reported ($0.17) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.40) by $0.23. The business had revenue of $4.59 billion for the quarter, compared to analysts’ expectations of $4.94 billion. Tenet Healthcare had a negative return on equity of 5.61% and a negative net margin of 2.85%. The business’s revenue was down 5.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.16 EPS. equities analysts anticipate that Tenet Healthcare will post 0.69 EPS for the current year.

Several equities analysts have recently issued reports on THC shares. Citigroup reiterated a hold rating and set a $16.00 target price on shares of Tenet Healthcare in a report on Thursday, September 14th. Mizuho reiterated a neutral rating and set a $14.00 target price on shares of Tenet Healthcare in a report on Thursday, September 14th. Zacks Investment Research lowered shares of Tenet Healthcare from a hold rating to a strong sell rating in a report on Tuesday, September 19th. Jefferies Group reiterated a buy rating and set a $24.00 target price on shares of Tenet Healthcare in a report on Thursday, September 21st. Finally, Royal Bank of Canada reiterated a hold rating and set a $19.00 target price on shares of Tenet Healthcare in a report on Monday, September 25th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company. The company has an average rating of Hold and an average target price of $18.50.

TRADEMARK VIOLATION NOTICE: This piece of content was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://ledgergazette.com/2018/01/13/tenet-healthcare-thc-issues-fy18-earnings-guidance.html.

About Tenet Healthcare

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply